在FLT3突变性急性髓性白血病中,为化学疗法提供最佳分子和功能反应而设计的脂聚合物/siRNA复合物
Aysha S Ansari1, Cezary Kucharski1, Remant Kc1
1Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, Alberta, Canada.
Acta biomaterialia
|September 5, 2024
概括
这项研究表明,使用FLT3 siRNA的非病毒性RNA干扰 (RNAi) 可以有效地向并减少FLT3-ITD阳性AML中的白血病细胞. 将这种RNAi疗法与现有药物相结合,显著增强了抗白血病活性,提供了一种有前途的新治疗方法.
科学领域:
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
- 纳米医学是一种纳米医学.
背景情况:
- 在新诊断的急性髓性白血病 (AML) 患者中,约有25%出现了FMS类型的氨酸激酶3 (FLT3) 内重复 (ITD).
- 目前用于FLT3突变AML的氨酸激酶抑制剂 (TKI) 面临诸多挑战,包括药物耐药性,短缓解持续时间和高复发率.
- RNA干扰 (RNAi) 提供了一个基因序列特定的治疗策略,具有个性化医学的潜力.
研究的目的:
- 研究FLT3-ITD阳性AML中FLT3-向短干扰RNA (siFLT3) 的非病毒传递系统的有效性.
- 评估将siFLT3治疗与AML目前的临床治疗相结合的可行性.
- 评估非病毒传递系统在恶性与健康细胞中的安全性和选择性.
主要方法:
- 使用脂聚合物纳米复合物用于非病毒性传递siFLT3到FLT3-ITD阳性AML细胞系和初级细胞.
- 评估治疗后的细胞增殖,细胞亡和基因/蛋白质表达水平 (FLT3 mRNA和蛋白质).
- 评估了使用诺鲁比和吉尔特里尼布的联合治疗效果,并测试了健康供体细胞的选择性.
主要成果:
- siFLT3纳米复合物治疗显著降低了AML细胞增殖和诱导的亡.
- 观察到FLT3在mRNA和蛋白质水平的下调,以及减少白血病干细胞殖民地形成.
- 脂聚合物/siFLT3复合体对恶性AML细胞具有选择性毒性,节省健康细胞,组合疗法增强了抗白血病活性.
结论:
- 使用脂聚合物复合物的非病毒性RNAi输送是AML分子治疗的有希望的策略.
- 这种方法有效地向白血病细胞中的FLT3基因,并且可以通过与现有的化疗相结合来加强.
- RNAi疗法具有作为解决AML异质性的当前治疗方式的辅助的潜力.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K


